Efficacy of Novel Drug-combinations for Relief of Psoriasis
Paused
Conditions studied: Psoriasis
In brief
ENDURE is a prospective, observational study aimed to document clinical response and side effects associated with compounded psoriasis medications when prescribed as routine care. As a secondary initiative, this study will assess methotrexate systemic absorption and toxicity in patients prescribed a methotrexate-containing compounded formulation.
Key facts
- Study ID
- NCT02394301
- Run by
- Medimix Specialty Pharmacy, LLC
- People needed
- 200
- Starts
- 2015-02-01
- Expected to finish
- 2015-12-01
- Last updated by the study team
- 2015-05-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- >18 years of age
- Diagnosis of psoriasis vulgaris
- Being initiated on a topical compounded medication for psoriasis from Medimix Specialty Pharmacy containing at least 3 of the following ingredients as part of standard of care: corticosteroid, methotrexate, retinoic acid, vitamin D3 or synthetic analog, urea, AND/OR a shampoo/spray containing a corticosteroid and vitamin D3 or synthetic analog for the first time.
You may not qualify if…
- Pregnancy \& nursing
- Active infectious disease
- Kidney abnormalities
- Blood deficiencies
- Alcohol consumption
- Immunodeficiency syndromes
- History of systemic psoriasis medications, including conventional DMARDs, oral retinoids, oral calcineurin inhibitors, TNF-inhibitors, and monoclonal antibodies within the past 120 days
- Current or planned use of concomitant psoriasis medications and/or phototherapy
- Any additional health conditions or concomitant use of other prescription/over-the-counter products that may confound the study results at the discretion of the study investigators
Where it is running
- The Medimix Specialty Pharmacy, LLC — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.